Janux Therapeutics Inc Cash Flow Reinvestment Rate
Latest as of March 2021:
25.65x
Janux Therapeutics Inc cash flow reinvestment rate. Janux Therapeutics Inc (JANX) has a Cash Flow Reinvestment Rate of 25.65x as of March 2021, reinvesting $142.67 Million (capex $153.00K plus investments $-142.52 Million) from operating cash flow of $5.56 Million. Explore Janux Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
25.65x
(Capex + Investments) / Operating CF
Total Reinvested
$142.67 Million
Capex + Investments
Operating Cash Flow
$5.56 Million
USD
Capital Expenditures
$153.00K
USD
Janux Therapeutics Inc Cash Flow Reinvestment Rate by Year (None–None)
Janux Therapeutics Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Janux Therapeutics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Janux Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow